Skip to main content

Table 6 Patient-reported outcomes in patients with and without care coordination during the campaign period

From: Impact of care coordination on oral anticoagulant therapy among patients with atrial fibrillation in routine clinical practice in Japan: a prospective, observational study

 

With care coordination

Without care coordination

MMAS-8

N = 13

N = 22

 Total score, median (IQR)

1 (1, 1.5)

1 (0.75, 1)

 Adherence levela, n (%)

  Low

13 (100.0)

22 (100.0)

  Medium

0 (0.0)

0 (0.0)

  High

0 (0.0)

0 (0.0)

ACTS score

N = 14

N = 22

 Burden

  Burden score, median (IQR)

57.5 (55, 60)

59 (57, 60)

  Global question about burdens (Item 13), median (IQR)

1 (1, 2)

1 (1, 1)

 Benefit

  Benefit score, median (IQR)

10.5 (9, 12)

12.5 (11, 15)

  Global question about benefits (Item 17), median (IQR)

3 (3, 3)

4 (3, 5)

  1. Use of the©MMAS is protected by US and International copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, MMAS Research (MORISKY) 16,636 159th Place SE, Renton WA 98058, dmorisky@gmail.com
  2. Abbreviations: MMAS-8 Morisky 8-Item Medication Adherence Scale, ACTS Anti-Clot Treatment Scale, IQR Interquartile range
  3. aAdherence level: low adherence, total score < 6; medium adherence, total score 6 to < 8; high adherence, total score = 8